IBDEI1GN ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23357,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,23357,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,23358,0)
 ;;=C78.7^^105^1173^95
 ;;^UTILITY(U,$J,358.3,23358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23358,1,3,0)
 ;;=3^Secondary Malig Neop of Liver/Intrahepatic Bile Duct
 ;;^UTILITY(U,$J,358.3,23358,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,23358,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,23359,0)
 ;;=C79.31^^105^1173^93
 ;;^UTILITY(U,$J,358.3,23359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23359,1,3,0)
 ;;=3^Secondary Malig Neop of Brain
 ;;^UTILITY(U,$J,358.3,23359,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,23359,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,23360,0)
 ;;=C79.49^^105^1173^98
 ;;^UTILITY(U,$J,358.3,23360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23360,1,3,0)
 ;;=3^Secondary Malig Neop of Nervous System
 ;;^UTILITY(U,$J,358.3,23360,1,4,0)
 ;;=4^C79.49
 ;;^UTILITY(U,$J,358.3,23360,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,23361,0)
 ;;=C79.32^^105^1173^94
 ;;^UTILITY(U,$J,358.3,23361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23361,1,3,0)
 ;;=3^Secondary Malig Neop of Cerebral Meninges
 ;;^UTILITY(U,$J,358.3,23361,1,4,0)
 ;;=4^C79.32
 ;;^UTILITY(U,$J,358.3,23361,2)
 ;;=^5001348
 ;;^UTILITY(U,$J,358.3,23362,0)
 ;;=C79.51^^105^1173^91
 ;;^UTILITY(U,$J,358.3,23362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23362,1,3,0)
 ;;=3^Secondary Malig Neop of Bone
 ;;^UTILITY(U,$J,358.3,23362,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,23362,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,23363,0)
 ;;=C79.52^^105^1173^92
 ;;^UTILITY(U,$J,358.3,23363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23363,1,3,0)
 ;;=3^Secondary Malig Neop of Bone Marrow
 ;;^UTILITY(U,$J,358.3,23363,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,23363,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,23364,0)
 ;;=C79.70^^105^1173^90
 ;;^UTILITY(U,$J,358.3,23364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23364,1,3,0)
 ;;=3^Secondary Malig Neop of Adrenal Gland,Unspec
 ;;^UTILITY(U,$J,358.3,23364,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,23364,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,23365,0)
 ;;=C83.30^^105^1173^12
 ;;^UTILITY(U,$J,358.3,23365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23365,1,3,0)
 ;;=3^Diffuse Large B-Cell Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,23365,1,4,0)
 ;;=4^C83.30
 ;;^UTILITY(U,$J,358.3,23365,2)
 ;;=^5001571
 ;;^UTILITY(U,$J,358.3,23366,0)
 ;;=C83.39^^105^1173^11
 ;;^UTILITY(U,$J,358.3,23366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23366,1,3,0)
 ;;=3^Diffuse Large B-Cell Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,23366,1,4,0)
 ;;=4^C83.39
 ;;^UTILITY(U,$J,358.3,23366,2)
 ;;=^5001580
 ;;^UTILITY(U,$J,358.3,23367,0)
 ;;=C83.50^^105^1173^31
 ;;^UTILITY(U,$J,358.3,23367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23367,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,23367,1,4,0)
 ;;=4^C83.50
 ;;^UTILITY(U,$J,358.3,23367,2)
 ;;=^5001581
 ;;^UTILITY(U,$J,358.3,23368,0)
 ;;=C83.59^^105^1173^30
 ;;^UTILITY(U,$J,358.3,23368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23368,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,23368,1,4,0)
 ;;=4^C83.59
 ;;^UTILITY(U,$J,358.3,23368,2)
 ;;=^5001590
 ;;^UTILITY(U,$J,358.3,23369,0)
 ;;=C81.90^^105^1173^22
 ;;^UTILITY(U,$J,358.3,23369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23369,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site,Unspec
